NANETS treatment guidelines: Well-differentiated neuroendocrine tumors of the stomach and pancreas

Matthew H. Kulke, Lowell B. Anthony, David L. Bushnell, Wouter W. De Herder, Stanley J. Goldsmith, David S. Klimstra, Stephen J. Marx, Janice L. Pasieka, Rodney F. Pommier, James C. Yao, Robert T. Jensen

    Research output: Contribution to journalReview article

    336 Scopus citations

    Abstract

    Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.

    Original languageEnglish (US)
    Pages (from-to)735-752
    Number of pages18
    JournalPancreas
    Volume39
    Issue number6
    DOIs
    StatePublished - Aug 2010

    Keywords

    • carcinoid
    • gastric
    • guidelines
    • islet cell
    • review

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Hepatology
    • Endocrinology

    Fingerprint Dive into the research topics of 'NANETS treatment guidelines: Well-differentiated neuroendocrine tumors of the stomach and pancreas'. Together they form a unique fingerprint.

  • Cite this

    Kulke, M. H., Anthony, L. B., Bushnell, D. L., De Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., & Jensen, R. T. (2010). NANETS treatment guidelines: Well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas, 39(6), 735-752. https://doi.org/10.1097/MPA.0b013e3181ebb168